SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Introgen Therapeutics
An SI Board Since February 2004
Posts SubjectMarks Bans Symbol
802 21 0 INGN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
252Curing Cancer with p53 David Lane, Ph.D. Volume 350:2711-2712 June 24, 200zeta19613/20/2005
251<Short Selling INGN> Ya' a INGN short seller dah'ling ..My gut tezeta19613/19/2005
250<i> Possible reason for INGN weakness today?</i> You mean besides pJibacoa3/18/2005
249Possible reason for INGN weakness today? A new setback for gene therapy By Lukzeta19613/18/2005
248Thanks Tuck..printed them out..Zeta Edit: I'm quite struck at how their prezeta19613/17/2005
247Ah, the reason those are available is that January '05 is their current freetuck3/17/2005
246I was able to sidle through the side door into Molecular Therapy. I came up wittuck3/17/2005
245Tuck you make a good case for perhaps P3's not providing enough data for thezeta19613/17/2005
244You did beat me!..by a nose<g> Just got here..<g> About to tell zeta19613/17/2005
243Well, I thought I will mention this before Zeta beats me to it. (She has been quJibacoa3/17/2005
242Well, after the strong performance yesterday afternoon the stock didn't needJibacoa3/17/2005
241>>Did indicate that the P3's may not need to be completed..no concretetuck3/17/2005
240INGN CC..well..it's always a great conversation piece on the YMB<g>!! zeta19613/16/2005
239Thanks Tuck..I agree..very slow, dry PR machine this year..on first look, it appzeta19613/16/2005
238[Nanoparticle-Mediated mda-7/IL-24 Gene Delivery -- lung cancer] INGN just put tuck3/16/2005
237FUS1 and Iressa resistant NSCLC Abstract Number: 2707 Presentation Title: Synzeta19613/16/2005
236interesting tweak of p53 for cervical cancer..? more effective than wild p53?..ozeta19613/16/2005
235hTERT..I believe this is part of the 007/009 oncolytic viral program..received czeta19613/16/2005
234A-d TNF-alpha Abstract Number: 2016 Presentation Title: Threshold for radiatizeta19613/16/2005
233Abstract Number: 3378 ( Here's Fisher's paper on the PEG3 promotor and zeta19613/16/2005
232FUS-1, lung cancer interesting work with Naproxen.. Abstract Number: 3345 Prezeta19613/16/2005
231AACR..Mda7, Fisher the founder is the senior author of a couple of these.. Mostzeta19613/16/2005
230AACR abstracts: Abstract Number: 3358 Presentation Title: A novel synthetic hzeta19613/16/2005
229Apparently some people liked it.<g> There were some nice upticks in the lJibacoa3/14/2005
228No I didn't Bernard..very busy today..I will try in the morning..hit the YMBzeta19613/14/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News